Announcements Trials
Browse Landscape

Status

Completed 4Suspended 2Terminated 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Neoplasms 518Breast Neoplasms 461Lung Neoplasms 256Prostatic Neoplasms 235Colorectal Neoplasms 218Carcinoma, Non-Small-Cell Lung 188Pancreatic Neoplasms 157Stomach Neoplasms 140Carcinoma, Hepatocellular 136Ovarian Neoplasms 120Multiple Myeloma 98Melanoma 95Head and Neck Neoplasms 95Esophageal Neoplasms 94Urinary Bladder Neoplasms 87Disease 87Lymphoma 79Uterine Cervical Neoplasms 78Hematologic Neoplasms 77Liver Neoplasms 76Brain Neoplasms 76Endometrial Neoplasms 73Neoplasm Metastasis 65Leukemia, Myeloid, Acute 65Colonic Neoplasms 61Rectal Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Leukemia 54Sarcoma 53Glioma 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × Dyslipidemias × Clear all
NCT04442334 2023-01-06

The European NAFLD Registry

Newcastle University

Recruiting
10,000 enrolled
GastrointestinalOther

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Hypertension, Liver Cirrhosis, Obesity, Dyslipidemias, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡